(4Z)-5-Chlor-4-hexensaeure | 66478-26-0

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: (4Z)-5-Chlor-4-hexensaeure
• 英文别名: (4Z)-5-Chloro-4-hexenoic Acid；5-chloro-4-hexenoic acid；(Z)-5-chlorohex-4-enoic acid
• CAS: 66478-26-0
• 化学式: C₆H₉ClO₂
• 分子量: 148.589
• InChiKey: SJAZDJCBOMMENQ-HYXAFXHYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  9
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (4Z)-5-Chlor-4-hexensaeure 生成 <(5Z)-6-Chlor-2-oxo-5-heptenyliden>-triphenylphosphoran
  参考文献：
  名称：

  DE2635985

  摘要：

  公开号：
• 作为产物：
  描述：

  3-Chlor-2-butenyl-malonsaeureaethylester 在 氢氧化钾 作用下， 以 乙醇 为溶剂， 生成 (4Z)-5-Chlor-4-hexensaeure
  参考文献：
  名称：

  DE2635985

  摘要：

  公开号：

文献信息

• Prostanoic acid derivatives and their preparation
  申请人：Schering Aktiengesellschaft

  公开号：US04489092A1

  公开（公告）日：1984-12-18

  Prostanoic acid derivatives of the formula ##STR1## wherein R.sub.1 is an acid, ester, amide or hydroxyalkylene group; R.sub.2 and R.sub.3 are H or alkyl; R.sub.4 and R.sub.5 are both CH.sub.3 or one is Cl and the other is CH.sub.3 ; A is CH.sub.2 CH.sub.2 or --CH.dbd.CH; B is CH.sub.2 CH.sub.2, trans-CH.dbd.CH, --C.tbd.C-- or ##STR2## W is free or functionally modified hydroxyalkylene or carbonyl; Z is free or functionally modified hydroxymethylene or carbonyl; X Y is either ##STR3## or, when Z is free or functionally modified hydroxymethylene, ##STR4## or, when Z is free or functionally modified carbonyl, --CH.dbd.CH--, R.sub.12 being H, CH.sub.3, CH or free or functionally modified hydroxy; and physiologically acceptable salts thereof when R.sub.1 is an acid group, possess pharmacological activity, including abortion triggering activity.

  化合物的结构式为##STR1## 其中R.sub.1是酸、酯、酰胺或羟基烷基基团；R.sub.2和R.sub.3是H或烷基；R.sub.4和R.sub.5均为CH.sub.3或一个为Cl，另一个为CH.sub.3；A为CH.sub.2 CH.sub.2或--CH.dbd.CH；B为CH.sub.2 CH.sub.2、反式-CH.dbd.CH、--C.tbd.C--或##STR2##；W为自由或功能修饰的羟基烷基或羰基；Z为自由或功能修饰的羟甲基或羰基；X Y为##STR3##或当Z为自由或功能修饰的羟甲基时，为##STR4##或当Z为自由或功能修饰的羰基时，为--CH.dbd.CH--，其中R.sub.12为H、CH.sub.3、CH或自由或功能修饰的羟基；当R.sub.1为酸基团时，其生理上可接受的盐具有药理活性，包括引发流产的活性。
• 7-OXOPROSTACYCLIN DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF
  申请人：SCHERING AKTIENGESELLSCHAFT

  公开号：EP0059756B1

  公开（公告）日：1985-08-28
• COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE
  申请人：Flagship Pioneering Innovations V, Inc.

  公开号：US20210289794A1

  公开（公告）日：2021-09-23

  The invention comprises methods for decreasing colonization by a bacterium of a gut of a stink bug, the method comprising providing a composition comprising vanillin or an analog thereof; and delivering said composition to an egg from which the stink bug will hatch, whereby colonization by the bacterium within the gut of the stink bug hatched from the egg treated with the composition is decreased relative to a stink bug hatched from an untreated egg. In some embodiments, the decrease in colonization by the bacterium decreases the fitness of the stink bug, e.g., decreases reproductive ability, survival, rate of development, number of eggs, number of hatched eggs, adult emergence rate, body length, body width, body mass, or cuticle thickness. In some embodiments of the methods herein, the bacterial colonization-disrupting agent is an inhibitor of bacterial metabolism. In some embodiments, the bacterial colonization-disrupting agent is a polyhydroxyalkanoate (PHA) synthesis inhibitor.
• US4284646A
  申请人：——

  公开号：US4284646A

  公开（公告）日：1981-08-18
• US4359467A
  申请人：——

  公开号：US4359467A

  公开（公告）日：1982-11-16